Skip to main content

29 Year Safety Update: Botox and Pregnancy With UK Guidance

By September 18, 2026Artist
Clinician discussing Botox exposure during pregnancy

Elective cosmetic Botox is not recommended during pregnancy, and that guidance holds even though the human safety data are more reassuring than most people expect. If you had an injection before you realized you were pregnant, the available evidence does not point to increased birth defects, but you should still tell your midwife or obstetrician. If Botox is treating a medical condition like chronic migraine, that decision gets made case by case with your specialist, not by a blanket rule.

TL;DR:

  • Evidence shows no increased risk of birth defects from Botox exposure during early pregnancy, but data remain limited, especially for later trimesters.
  • Most exposures occurred before pregnancy recognition, often in the first trimester, with sparse data on continuous or higher-dose therapeutic use.
  • UK guidance recommends avoiding elective cosmetic Botox during pregnancy due to limited safety data, while therapeutic use requires case-by-case medical decision-making.
  • If you had Botox before realizing you were pregnant, inform your healthcare team and continue routine antenatal care without additional testing unless symptoms develop.
  • Breastfeeding appears safe after Botox, as studies show minimal toxin passage into breast milk and no reported infant harm, but many clinicians recommend waiting until breastfeeding ends.
Thegoodskinclub
Make Informed Aesthetic Decisions
Dr Lydia Pavey provides expert Botox and advanced injectable treatments from clinics in Harley Street and South Oxfordshire.

Visit Thegoodskinclub

Table of Contents

Botox and Pregnancy Safety: What the Human Evidence Shows

The strongest piece of evidence on Botox and pregnancy safety comes from a cumulative analysis spanning 29 years of pharmaceutical safety monitoring. Researchers tracked prospective pregnancy exposures to onabotulinumtoxinA, the medical name for Botox, and followed them through to birth outcomes.

Statistic callout: Among 152 live births with prospective exposure data, 97.4% had normal outcomes and the major birth defect rate was 0.7%, which sits within the range of background birth defect rates seen in the general population regardless of Botox exposure.

That figure matters because background rates for major birth defects across the general population typically run higher, closer to 3 to 6%. A 0.7% rate in a population that received Botox during pregnancy doesn’t suggest the drug is pushing risk upward. It suggests the opposite: no detectable signal above what happens anyway, with or without Botox.

But the data have real limits, and a responsible answer to “is Botox safe during pregnancy” has to include them:

  • Most recorded exposures happened during the preconception window or the first trimester, often before the patient knew she was pregnant. Second and third trimester exposure data remain sparse, so the reassurance applies most confidently to early, incidental exposure.
  • Postmarketing safety databases rely on voluntary reporting, which introduces selection bias. Women who experienced complications may be more likely to report them, or less likely, depending on the circumstances, and that skews any raw percentage.
  • Dose ranges across the 152 cases varied by indication, from small cosmetic doses to higher therapeutic doses for conditions like cervical dystonia, and the analysis did not isolate cosmetic-only outcomes with enough precision to give a cosmetic-specific figure.
  • Sample size, while the largest available for this drug, is still small next to the tens of thousands of pregnancies needed to detect rare complications or subtle neurodevelopmental effects with statistical confidence.

That last point is the one clinicians come back to. A 152-birth sample can rule out large, obvious risks. It cannot rule out something that happens in 1 in 2,000 pregnancies, and it says almost nothing about how a child’s nervous system develops at age five or ten, because that kind of follow-up simply wasn’t part of the tracking. MotherToBaby’s review of the existing studies reaches a similar conclusion: no identified increase in birth defects or pregnancy complications in the datasets reviewed, but the studies are limited, and any decision should involve your clinician rather than a home judgment call.

Separate data from the Medicines in Pregnancy resource put the studied population at roughly 250 pregnant women with no identified risk pattern. Again: reassuring, not proof of safety in the way a decade of randomized trials would be. That gap between “no signal found” and “proven safe” is exactly why every major guidance body still recommends avoiding elective cosmetic use while pregnant, even as they reassure patients who were exposed unknowingly.

Botox and Pregnancy Safety: What the Human Evidence Shows — overview diagram

What UK Guidance Says About Botox During Pregnancy

The UK Teratology Information Service, known as UKTIS, is the reference point most UK clinicians use when a patient asks about botulinum toxin exposure in pregnancy. Its position is direct: avoid elective cosmetic botulinum toxin A treatments during pregnancy because human data remain limited, even though correctly injected Botox is not expected to cause significant systemic exposure.

That second half of the sentence is worth sitting with. UKTIS isn’t saying Botox floods the bloodstream and threatens the fetus. It’s saying the drug, when injected properly into a targeted muscle, stays largely local. The caution is about incomplete data, not observed harm.

Three things follow from that guidance in practice:

  • Elective and cosmetic use gets deferred. There’s no medical necessity forcing a decision under uncertainty, so the pragmatic choice is to wait.
  • Therapeutic use is reserved for cases with no suitable alternative. Chronic migraine, severe muscle spasm, and similar conditions sometimes leave few good options, and untreated disease can carry its own risks to mother and baby.
  • Routine antenatal care is usually sufficient after low-level exposure. UKTIS doesn’t recommend extra scans or invasive monitoring purely because someone had cosmetic Botox before learning she was pregnant.

MotherToBaby’s guidance lines up closely, describing the picture as “limited studies, no clear increased risk identified,” and pointing patients back toward their existing care team rather than specialist intervention. This consistency between UK and US-facing sources matters. When teratology services on both sides of the Atlantic land on the same pragmatic position, that’s a stronger signal than any single study.

In practice, this means a woman who received cosmetic Botox weeks before a positive pregnancy test doesn’t need a referral to a fetal medicine unit. Her 20-week anomaly scan, part of routine NHS antenatal care, is generally considered adequate. Clinicians reserve referral to a teratology or fetal medicine service for cases involving higher systemic exposure, unusual symptoms, or a therapeutic dose regimen used repeatedly through pregnancy. If your case doesn’t fit that description, the appropriate response is documentation and reassurance, not escalation.

If You Had Botox Before You Knew You Were Pregnant

Realizing you had a cosmetic treatment before a positive pregnancy test is common, and it rarely changes the outlook for your pregnancy. Small, localized cosmetic doses are not the same exposure pattern that raises red flags in toxicology, and nothing in the current data suggests fetal harm from a standard treatment area like frown lines or crow’s feet.

Here’s what to actually do, in order:

  1. Tell your midwife or obstetrician at your next appointment, even if it feels minor. Give them the approximate date, the treatment area, and the dose if you know it. This goes in your notes so your care team has the full picture.
  2. Continue your routine antenatal schedule. Your 20-week anomaly scan will check fetal development as it normally would; there’s no need to request additional imaging unless your clinician recommends it based on your specific history.
  3. Ask about reporting to UKTIS if your clinician suggests it. UKTIS collects exposure reports to keep building the case dataset that makes future guidance more precise. Your case, even with a reassuring outcome, adds to the evidence base.
  4. Watch for maternal symptoms, not fetal symptoms. The exposure that actually warrants urgent attention isn’t a cosmetic dose. It’s systemic botulism from contamination or excessive dosing, which presents as generalized muscle weakness, drooping eyelids, difficulty swallowing, or breathing trouble.

If any of those systemic symptoms appear, that’s an emergency, not a wait and see. Call 999 or go to A&E immediately, because systemic botulinum toxicity in pregnancy requires different management entirely, potentially including antitoxin treatment, and time matters.

Pro Tip: Bring the treatment date and clinic name to your booking or your next midwife appointment rather than waiting to be asked. Antenatal teams see this question often enough that they have a standard, calm response ready. Volunteering the information early avoids a rushed conversation later in pregnancy.

For everyone else, meaning the overwhelming majority of women reading this after a standard cosmetic session, the message from UKTIS and MotherToBaby is consistent: reassurance, not alarm, is the appropriate response, and no extra intervention beyond routine antenatal care is typically needed.

Cosmetic Botox vs. Therapeutic Use During Pregnancy

Cosmetic and therapeutic Botox get treated very differently once pregnancy enters the picture, and that distinction is the single most important nuance in this entire topic. Cosmetic use has no medical upside to weigh against the uncertainty, so pausing it costs nothing clinically. Therapeutic use is a different calculation entirely.

Conditions commonly treated with onabotulinumtoxinA include:

  • Chronic migraine prophylaxis, where injections reduce frequency and severity of debilitating headache episodes.
  • Cervical dystonia and other spasm or muscle-tone disorders.
  • Hyperhidrosis, or excessive sweating, particularly in the underarms, palms, or soles.
  • Bladder dysfunction, including overactive bladder that hasn’t responded to other treatments.

For these patients, stopping treatment isn’t neutral. Untreated chronic migraine during pregnancy can mean weeks of debilitating pain, poor sleep, and reliance on other medications that may carry their own risks. That’s the clinical trade-off specialists actually weigh: continuing a treatment with reassuring, if limited, safety data sometimes beats switching to an alternative with less pregnancy-specific evidence, or leaving a serious condition unmanaged.

This is a specialist decision, not a self-directed one. If you’re on Botox for a medical condition and become pregnant, or are planning to, talk to the prescribing neurologist, urologist, or GP directly. They’ll document the risk-benefit reasoning, consider dose reduction or spacing, and may loop in a teratology service for a second opinion. That documentation matters both for your care and for the safety data future patients will benefit from.

Timing: Conception Planning and When to Resume Botox

OnabotulinumtoxinA’s effects typically last three to six months in most adults, though individual variation is common depending on dose, muscle group, and metabolism. That duration matters for two separate planning questions: when to try to conceive after treatment, and when it’s reasonable to resume treatment postpartum.

Because localized cosmetic doses produce minimal systemic exposure, there’s no strict pharmacological clock forcing you to wait a set number of months before trying to conceive. Still, the conservative and widely used approach among UK clinics is straightforward:

  • Defer elective cosmetic injections once you’re actively pregnant and through breastfeeding, following the UKTIS position.
  • If you’re trying to conceive and had a recent treatment, mention the date at your first booking appointment. There’s no evidence requiring you to delay conception, but your clinician should have the full timeline.
  • If treatment happened shortly before a positive pregnancy test, tell both your antenatal team and, if relevant, your fertility clinic, since some fertility protocols document all medications and treatments during the conception window as a matter of routine, not because Botox specifically raises concern.

A useful way to frame it: the drug’s local effect lasting three to six months is not the same as a systemic clearance window, and it isn’t the reason for the pregnancy-specific caution. The caution exists because of incomplete data, not because Botox lingers in the body waiting to cause harm months later. Once you understand how long Botox typically lasts, the postpartum resumption question becomes a matter of personal readiness and breastfeeding status rather than a fixed pharmacological deadline.

Botox During Breastfeeding: What You Need to Know

Botox during breastfeeding gets less attention than pregnancy, but the underlying evidence is arguably more reassuring. Botulinum toxin is a large protein molecule, and MotherToBaby’s assessment concludes it is not expected to pass into breast milk in meaningful amounts, based on both its molecular structure and the limited studies that have directly measured it.

The small number of studies that tested breast milk after maternal Botox treatment did not detect the toxin in milk samples, and no adverse effects were reported in breastfed infants. That’s a thinner evidence base than most parents would like, but it’s consistent, not contradictory, across the sources available.

Practical guidance breaks down like this:

  • For elective cosmetic treatments, many clinicians still suggest waiting until breastfeeding is finished, largely out of the same precautionary instinct that governs pregnancy advice, rather than any specific documented harm.
  • Decisions can be individualized. Some women choose to resume cosmetic treatment while breastfeeding after a conversation with their provider about the current evidence and their own comfort level.
  • For therapeutic use, coordinate directly with the prescribing specialist and your infant’s feeding team. Chronic migraine or severe hyperhidrosis during the postpartum period is exhausting to manage untreated, and that context belongs in the decision.

There’s no single right answer here, and that’s a legitimate response, not a dodge. The data don’t show harm, but they’re not extensive enough to issue a blanket “always safe” verdict either.

Pregnancy-Safe Alternatives While You Pause Botox

Pausing elective Botox for the length of a pregnancy, and often through breastfeeding, doesn’t mean doing nothing about your skin or symptoms. It means shifting to approaches with a clearer safety profile for this specific stretch of time.

For skincare and appearance concerns, stick to the basics that carry no pregnancy-specific warnings:

  • Daily broad-spectrum sunscreen remains one of the most effective ways to prevent new lines and pigmentation from worsening, pregnancy or not.
  • Gentle, fragrance-light moisturizers support skin barrier function without introducing active ingredients that need pregnancy-specific vetting.
  • Vitamin C serums are generally considered pregnancy-safe and offer a genuine antioxidant and brightening benefit as a topical alternative.
  • Avoid retinoids and retinol-based products entirely during pregnancy. These are established teratogens in oral form and are avoided topically as a precaution, unlike Botox, where the concern is a data gap rather than known harm.

For medical symptoms typically managed with Botox, like chronic migraine or muscle spasm, non-drug strategies deserve a real conversation with your specialist rather than a Google search for substitutes. Physiotherapy, targeted stretching, and behavioral migraine management (sleep regularity, trigger tracking, hydration) can meaningfully reduce symptom burden for some patients. None of these replace a specialist’s input on whether a licensed alternative medication makes sense for your specific case.

Pro Tip: Keep a simple symptom or skin-concern diary through pregnancy. It gives you and your provider a clear picture of what actually needs treatment once you’re cleared to resume, rather than guessing based on memory months later.

The reassuring part of all this: nothing about pausing Botox during pregnancy is permanent, and nothing about the pause causes the treated area to age faster or “catch up.” Once you’re cleared to resume, the results pick back up exactly where a first-time treatment would start.

A Clinic’s View on Aftercare and When to Ask Questions

Thegoodskinclub, founded by Dr. Lydia Pavey, a level 7 qualified medical doctor practicing across Harley Street in London and Wallingford in South Oxfordshire, treats questions about Botox and pregnancy as a routine part of patient screening, not an edge case. Every consultation includes a direct question about pregnancy status and plans, because timing genuinely changes the treatment conversation.

The clinic’s broader aftercare approach reflects the same anatomy-led, precaution-first thinking that applies to the pregnancy question:

  • The 4 Hour Rule advises patients to remain upright and avoid lying down for several hours after injection, reducing the chance of product migration.
  • Strenuous exercise is typically paused for a set window post-treatment, mirroring the general caution UKTIS applies to systemic exposure concerns.
  • Patients are given clear guidance on common side effects and genuine red flags, so they know what’s a normal bruise and what actually warrants a call.

That same clarity, explain what’s known, name what isn’t, and give a specific next step, is exactly what a pregnancy-related exposure conversation deserves. If you’re due for treatment and there’s any chance you could be pregnant, that’s the first thing to raise before, not after, the appointment.

How Clinicians Actually Talk About This With Patients

In a real consultation, the conversation about Botox and pregnancy rarely sounds clinical or cold. It sounds like a specialist walking a patient through what’s known, what isn’t, and what that gap means for her specific situation. Most clinicians lead with the limits of the data before the reassurance, because patients trust the reassurance more when it isn’t the first thing they hear.

For inadvertent exposure, the language tends to be calm and specific: “The doses used in cosmetic treatment are small and stay local. The data we have on this don’t show an increased risk, and your routine scans will do exactly what they’d do anyway.” For therapeutic cases, the tone shifts toward partnership: “Let’s weigh what happens if we stop this against what we know, and don’t know, about continuing.”

The one thing every good version of this conversation includes is a direct prompt: bring up any past Botox treatment early in your antenatal visits, even if you think it’s irrelevant. Individualized assessment only works when your care team has the full timeline in front of them, not a version edited down to what you assumed mattered.

If you’re planning treatment after pregnancy and breastfeeding, Thegoodskinclub’s treatments page outlines current options, including anti-wrinkle injections starting from £249 for one area, £329 for two areas, and £399 for three areas, all performed by a GMC-registered doctor in a private clinic setting rather than a high-volume chain. Booking a consultation first lets you discuss your specific history, including any exposure during pregnancy, before any treatment decision is made.

The Gap Between “No Evidence of Harm” and “Proven Safe”

Most articles on this topic either overstate the risk, treating any Botox exposure as a crisis, or overstate the safety, treating the absence of red flags as proof there’s nothing to worry about. Both framings are lazy, and both do a disservice to someone trying to make a real decision.

The honest position is the uncomfortable one: the data are reassuring enough that panic isn’t warranted, and thin enough that “definitely safe” isn’t either. A 152-birth safety analysis is genuinely useful, it’s the best data available, but it’s a rounding error next to the sample sizes needed to catch rare risks. That’s not a criticism of the research. It’s just what postmarketing pharmaceutical data look like for a drug that isn’t routinely tested in pregnant populations for obvious ethical reasons.

What frustrates me about how this topic gets covered elsewhere is the false confidence in either direction. The precautionary advice from UKTIS isn’t fear-mongering. It’s the appropriate response to genuine uncertainty, and it costs an elective cosmetic patient almost nothing to follow. The reassurance for inadvertent exposure isn’t wishful thinking either. It’s a direct read of the actual numbers, which show no signal above background rates. Holding both of those truths at once is harder than picking a side, but it’s the only version of this advice that actually respects the reader’s intelligence.

If there’s one underrated point in all of this, it’s that the therapeutic cases deserve far more nuance than they usually get in general health content. Decisions about treatment involve weighing uncertainties and should be made in consultation with the relevant specialist, not based on general information alone.

— Anthony

Sources

For readers who want to go directly to the primary guidance rather than a summary of it, these are the sources this article draws from most heavily:

This article is general information, not a substitute for advice from a qualified doctor. Consult a qualified healthcare professional about your own circumstances before acting on anything here.

FAQ

What Happens if You Accidentally Get Botox While Pregnant?

Nothing alarming, based on current evidence: the best available data show no increased rate of birth defects among women exposed early in pregnancy, and routine antenatal care, including your standard 20-week scan, is typically all that’s needed. Tell your midwife or obstetrician about the exposure so it’s documented in your notes.

How Long After Botox Can I Get Pregnant?

There’s no strict medical waiting period, since localized cosmetic doses produce minimal systemic exposure and effects last roughly three to six months regardless of conception timing. The practical advice is simply to mention any recent treatment to your antenatal team once you conceive.

Can Botox Affect My Unborn Baby?

Available human data, including a 152-birth safety analysis showing outcomes consistent with background population rates, have not identified an increased risk to fetal development from Botox exposure. That said, data remain limited, which is why elective cosmetic use is still recommended against during pregnancy as a precaution.

Do Celebrities Still Get Botox When Pregnant?

Some public figures have discussed continuing cosmetic treatments during pregnancy, but that reflects personal choice rather than medical guidance. UKTIS and MotherToBaby both recommend avoiding elective cosmetic Botox during pregnancy regardless of what any individual chooses to do.

Leave a Reply

WhatsApp